Isopropyl Alcohol

Isopropyl Alcohol

SCHEMBL5735328

CC(C)O.O=S(=O)(O)c1ccccc1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BTKCACNA1CCACNA1DCACNA1FCACNA1SCACNA2D1CACNA2D2DRD2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQHRH1HTR2AP2RY12

The experimentally established mechanism targets of Isopropyl Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.76
SMN1; SMN2 Q16637 1/20 0.76
POLB P06746 2/20 0.52
CYP2D6 P10635 2/20 0.52
LMNA P02545 2/20 0.46
HTR6 P50406 1/20 0.46
ALDH1A1 P00352 5/20 0.46
TDP1 Q9NUW8 4/20 0.46
KDM4E B2RXH2 1/20 0.46
GMNN O75496 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
PMP22 Q01453 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NT5E P21589 1/20 0.44
PSIP1 O75475 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 2/20 0.43
NAPRT Q6XQN6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16046756 0.93 TSHR (0.73) TSHRSMN1; SMN2POLBCYP2D6LMNA
SCHEMBL5875401 0.91 TSHR (0.70) TSHRSMN1; SMN2POLBCYP2D6LMNA
SCHEMBL28902110 0.91 TSHR (0.70) TSHRSMN1; SMN2POLBCYP2D6LMNA
SCHEMBL16045501 0.89 TSHR (0.67) TSHRSMN1; SMN2POLBCYP2D6LMNA
Lactic Acid SCHEMBL232168 0.89 TSHR (0.67) TSHRSMN1; SMN2POLBCYP2D6LMNA
Isopropylamine SCHEMBL25405525 0.88 TSHR (0.73) TSHRSMN1; SMN2POLBCYP2D6LMNA
SCHEMBL27872661 0.88 TSHR (0.73) TSHRSMN1; SMN2POLBCYP2D6LMNA
Methyl Alcohol SCHEMBL2996522 0.87 TSHR (0.89) TSHRSMN1; SMN2POLBCYP2D6LMNA
Ethane SCHEMBL4196548 0.87 TSHR (0.89) TSHRSMN1; SMN2POLBCYP2D6LMNA
SCHEMBL597672 0.87 TSHR (1.00) TSHRSMN1; SMN2POLBCYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106045974-B A kind of bepotastine besilate at salt method 杭州和泽医药科技有限公司 2019-09-13 CN claimed
CN-106459022-B The preparation method of antifungal compound 北卡罗来纳维亚梅特制药公司 2019-08-02 CN disclosed
CN-106459022-A Antifungal compound process 维亚梅特制药公司 2017-02-22 CN disclosed
CN-100390170-C 5- (4- (2- (N-methyl-N- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate, process for its preparation, polymorphs I, II and III thereof and its use as pharmaceutical active ingredient SMITHKLINE BEECHAM PLC (GB) 2008-05-28 CN disclosed
EP-1448559-B1 5-(4-(2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE BENZENESULFONATE; PROCESS FOR ITS PREPARATION; POLYMORPHS I, II AND III THEREOF; AND ITS USE AS PHARMACEUTICAL ACTIVE INGREDIENT SMITHKLINE BEECHAM PLC (GB) 2006-12-27 EP disclosed
CN-1612875-A 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate, process for its preparation, polymorphs i, ii and iii thereof, and its use as pharmaceutical active SMITHKLINE BEECHAM PLC (GB) 2005-05-04 CN disclosed
EP-1448559-A1 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLIDINE-2,4-DIONE BENZENESULFONATE; PROCESS FOR ITS PREPARATION; POLYMORPHS I, II AND III THEREOF; AND ITS USE AS PHARMACEUTICAL ACTIVE INGREDIENT SMITHKLINE BEECHAM PLC (GB) 2004-08-25 EP disclosed
WO-2003045946-A1 5-(4-(2-(N-METHYL-N-(2-PYRIDIL) AMINO) ETHOXY) BENZYL) THIAZOLIDINE-2, 4-DIONE BENZENESULFONATE; PROCESS FOR ITS PREPARATION; POLYMORPHS I, II AND III THEREOF; AND ITS USE AS PHARMACEUTICAL ACTIVE INGREDIENT SMITHKLINE BEECHAM P.L.C. (GB) 2003-06-05 WO disclosed